Related Experiment Videos
Bilateral breast carcinoma: 28 years' experience
H Gülay1, E Hamaloğlu, O Bulut
1Department of Surgery, Hacettepe University School of Medicine, Ankara, Turkey.
World Journal of Surgery
|July 1, 1990
Summary
Bilateral breast carcinoma occurred in 4.06% of patients. A shorter interval between initial and second primary breast cancer diagnoses correlated with reduced survival rates, despite similar risk factors to unilateral cases.
Area of Science:
- Oncology
- Epidemiology
- Clinical Medicine
Background:
- Bilateral breast carcinoma (BBC) presents a complex clinical challenge.
- Understanding the characteristics and outcomes of BBC is crucial for patient management.
Purpose of the Study:
- To analyze the incidence and clinical features of bilateral breast carcinoma.
- To compare BBC patients with unilateral breast carcinoma (UBC) patients.
- To investigate the prognostic significance of the time interval between primary and secondary breast cancer diagnoses.
Main Methods:
- Retrospective review of 1,182 breast cancer patients diagnosed between 1959 and 1987.
- Identification of 48 patients (4.06%) with bilateral breast carcinoma.
- Comparison of clinical data between simultaneous and nonsimultaneous BBC cases, and between BBC and UBC cohorts.
Main Results:
- 48 patients (4.06%) had bilateral breast carcinoma; 8 simultaneous (0.68%) and 40 nonsimultaneous (3.38%).
- The mean interval between the first and second primary breast cancer was 86 months (range: 17-200 months).
- Second primary carcinomas showed higher rates of axillary metastasis (48% vs. 37.5%).
- Shorter time intervals between primary and secondary diagnoses were associated with poorer survival.
Conclusions:
- Bilateral breast carcinoma is a relatively uncommon but significant clinical entity.
- While risk factors like pregnancy and family history did not differ significantly, axillary metastasis was more prevalent in the second primary breast cancer.
- The time interval between diagnoses is a critical prognostic factor in bilateral breast carcinoma.